dc.contributor.author | Poutahidis, Theofilos | |
dc.contributor.author | Kleinewietfeld, Markus | |
dc.contributor.author | Erdman, Susan E. | |
dc.date.accessioned | 2014-06-19T18:32:51Z | |
dc.date.available | 2014-06-19T18:32:51Z | |
dc.date.issued | 2014-04 | |
dc.identifier.issn | 1664-3224 | |
dc.identifier.uri | http://hdl.handle.net/1721.1/88032 | |
dc.description.abstract | It is recently shown that beneficial environmental microbes stimulate integrated immune and neuroendocrine factors throughout the body, consequently modulating regulatory T-lymphocyte phenotypes, maintaining systemic immune balance, and determining the fate of preneoplastic lesions toward regression while sustaining whole body good health. Stimulated by a gut microbiota-centric systemic homeostasis hypothesis, we set out to explore the influence of the gut microbiome to explain the paradoxical roles of regulatory T-lymphocytes in cancer development and growth. This paradigm shift places cancer prevention and treatment into a new broader context of holobiont engineering to cultivate a tumor-suppressive macroenvironment. | en_US |
dc.description.sponsorship | National Institutes of Health (U.S.) (grant P30-ES002109) | en_US |
dc.description.sponsorship | National Institutes of Health (U.S.) (grant U01CA164337) | en_US |
dc.description.sponsorship | National Institutes of Health (U.S.) (grant RO1CA108854) | en_US |
dc.language.iso | en_US | |
dc.publisher | Frontiers Research Foundation | en_US |
dc.relation.isversionof | http://dx.doi.org/10.3389/fimmu.2014.00157 | en_US |
dc.rights | Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use. | en_US |
dc.source | Frontiers Research Foundation | en_US |
dc.title | Gut Microbiota and the Paradox of Cancer Immunotherapy | en_US |
dc.type | Article | en_US |
dc.identifier.citation | Poutahidis, Theofilos, Markus Kleinewietfeld, and Susan E. Erdman. “Gut Microbiota and the Paradox of Cancer Immunotherapy.” Front. Immunol. 5 (April 7, 2014). | en_US |
dc.contributor.department | Massachusetts Institute of Technology. Division of Comparative Medicine | en_US |
dc.contributor.mitauthor | Erdman, Susan E. | en_US |
dc.contributor.mitauthor | Poutahidis, Theofilos | en_US |
dc.relation.journal | Frontiers in Immunology | en_US |
dc.eprint.version | Final published version | en_US |
dc.type.uri | http://purl.org/eprint/type/JournalArticle | en_US |
eprint.status | http://purl.org/eprint/status/PeerReviewed | en_US |
dspace.orderedauthors | Poutahidis, Theofilos; Kleinewietfeld, Markus; Erdman, Susan E. | en_US |
mit.license | PUBLISHER_POLICY | en_US |
mit.metadata.status | Complete | |